Yeast research targets drug resistance battle

Evolution of a much-maligned yeast shows that drug resistance is a predictable outcome of exposure to drugs, say University of Toronto botanists.

Microbes that survive drug treatment often become drug-resistant. Researchers in the labs of Professors Jim Anderson and Linda Kohn of botany have determined how this happens by studying the yeast Candida albicans and its genetic changes when exposed to drugs. "Ultimately, our findings could lead to the development of companion drugs that target these sets of genes, delaying or preventing the evolution of resistance to the therapeutic drug," says doctoral student Leah Cowen, the study's lead author.

Researchers grew over 330 generations of the yeast - a common inhabitant of healthy humans that causes thrush, diaper rash and infections in women as well as life-threatening infections in immuno-compromised individuals - in the presence of the widely prescribed anti-fungal drug fluconazole. Drug resistance increased as the researchers had predicted. While they saw expected changes to the molecular pumps (which remove a variety of drugs from cells), they also noted changes in hundreds of genes. More surprisingly, they found the altered genes displayed three distinct patterns - a finding replicated in patient samples. Recognizing these patterns will make it easier for scientists to target drug therapy, Cowen says.


Contact: Lanna Crucefix
University of Toronto

Page: 1

Related biology news :

1. Yeast mutations offer window into human disease
2. Yeast model yields insights into Parkinsons disease
3. Yeast helps researchers better understand Parkinsons mystery
4. Yeast, wormwood & bacterial genes combine in microbial factory to make antimalarial drug
5. Yeast genomes reveal new sites of gene control
6. Yeast underscores complexity of genetic variation between people
7. Yeast Provides Evidence For Continuous Membrane Theory
8. Yeast Rises To A New Occasion
9. Bakers Yeast Causes Chemical Reactions And Sweet Smelling Labs
10. Poetically Timed With Spring, Budding Yeast Yield Possible Insight Into Male Fertility--And Infertility
11. Mutate Or Die: New Polymerase Gives Desperate Yeast An Option

Post Your Comments:

(Date:2/28/2020)... ... February 27, 2020 , ... ... its newest portfolio company. Established to develop and commercialize a manufacturing platform ... New Mexico State University (NMSU). The patent-pending technology results in membranes with ...
(Date:2/26/2020)... , ... February 25, 2020 , ... Renowned eye surgical ... the first practices in Texas to offer the FDA-approved, post-surgical, corrective Light Adjustable Lens ... have been placed with excellent results. Dell Laser Consultants is also currently involved in ...
(Date:2/21/2020)... ... ... Gateway Genomics , a leading developer of direct-to-consumer genetic tests that ... Inc. 5000 list of fastest-growing private companies in the United States. In this ... fastest-growing private company in the state, and #1 in the Health sector. ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... ... February 18, 2020 , ... ... microbiome populations down to the strain level, recently unveiled a novel DNA isolation ... efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA (ssDNA) in ...
(Date:2/11/2020)... , ... February 11, 2020 ... ... is pleased to announce the successful results from a long-term follow-up clinical ... the Inspan interspinous fixation device (INSPAN LLC). Unlike extension block design, the ...
(Date:2/5/2020)... ... ... Rare Disease Day® , held the last day in February each ... to raise awareness amongst the general public and decision-makers about rare diseases and their ... rare disease series will be shining the light on Rare Disease Day ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist ... on supporting the implementation of Multi-Attribute Methods (MAM) for characterizing and monitoring ...
Breaking Biology Technology:
Cached News: